PMID: 6160587Oct 1, 1980Paper

Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents

Proceedings of the National Academy of Sciences of the United States of America
B Y Rubin, S L Gupta

Abstract

Treatment of human fibroblast FS-4 cultures with human type II interferon preparations induced the synthesis of at least four proteins that were similar in size to four of the five proteins induced by type I interferons (Mr 120,000, 88,000, 67,000, and 56,000). However, the Mr 67,000 and 56,000 proteins were induced more strongly by type II than by type I interferon, and a counterpart of a Mr 80,000 protein induced by type I interferons was not noticeably induced by type II interferon preparations. We therefore compared type I and type II interferons for relative antiviral activities against different viruses (vesicular stomatitis, encephalomyocarditis, and vaccinia viruses and reovirus) and for cell growth-inhibitory activities on various cell types. The replication of vesicular stomatitis and encephalomyocarditis viruses was inhibited more strongly by type I interferon, whereas reovirus and vaccinia virus showed greater sensitivity to type II interferon preparations. This indicates that viruses may differ in their sensitivity to human type I and type II interferons and that the antiviral mechanisms induced by type I and type II interferons may have significant differences. The type I and type II interferons may have significa...Continue Reading

References

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·I M Kerr, R E Brown
Mar 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·L A Ball, C N White
Dec 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P J FarrellP Lengyel
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·A ZilbersteinM Revel
Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·E Knight, B D Korant
Oct 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·S L GuptaS L Holmes
Sep 18, 1977·Blut·H Strander
Jan 1, 1978·Annual Review of Biochemistry·A B PardeeR F Kletzien
Oct 27, 1978·Biochimica Et Biophysica Acta·I Gresser, M G Tovey
Jul 27, 1979·Biochemical and Biophysical Research Communications·M De LeyP De Somer
Jan 1, 1977·Proceedings of the Society for Experimental Biology and Medicine·H M JohnsonS Baron
Sep 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·B LebleuP Lengyel
Aug 15, 1975·European Journal of Biochemistry·R A Laskey, A D Mills
Jan 1, 1964·Biochemical and Biophysical Research Communications·J Taylor
Apr 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·A B Pardee
May 1, 1980·Molecular Immunology·M Wiranowska-StewartW E Stewart

❮ Previous
Next ❯

Citations

May 1, 1993·Journal of Medical Virology·J E Lavine, D Ganem
Dec 1, 1989·Journal of Neuroscience Research·P A EcclestonR Mirsky
Jan 1, 1987·Cancer Metastasis Reviews·M Shearer, J Taylor-Papadimitriou
Jan 1, 1987·Journal of Cancer Research and Clinical Oncology·S E Krown
Jan 1, 1987·Journal of Cancer Research and Clinical Oncology·U Elsässer-BeileE Schöpf
Jan 1, 1990·Cancer Immunology, Immunotherapy : CII·H M BlottiereZ Steplewski
Jan 1, 1984·Neurosurgical Review·M Nagai, T Arai
Apr 1, 1991·Developmental Biology·M E BarishS S Raissdana
Jan 1, 1984·Pharmacology & Therapeutics·G C Sen
Apr 1, 1994·Pharmacology & Therapeutics·T C Johnson
Jan 22, 1998·Veterinary Immunology and Immunopathology·K D SongJ Y Han
Dec 3, 2003·Revue médicale de Bruxelles·P Lewalle, P Martiat
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·G H WongJ W Schrader
Aug 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·S J ScahillW Fiers
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B D WilliamsonL J Old
Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R L FortiJ T Forbes
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·F H Sarkar, S L Gupta
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S M HammerR M Rose
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·F Tirone, E M Shooter
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·J B SunC Czerkinsky
Jan 1, 1984·Biotechnology & Genetic Engineering Reviews·M D Edge, R Camble
Mar 1, 1987·The Journal of Cell Biology·R FrieselT Maciag
Mar 1, 1984·The Journal of Experimental Medicine·D S Stone-WolffJ Vilcek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.